Virginia Mihalick

Phase 1B, Randomized, Double-Blinded, Dose Escalation, Single-Center, Repeat Dose Safety and Pharmacodynamics Study of the Oral NLRP3 Inhibitor Dapansutrile in Subjects With NYHA II–III Systolic Heart Failure

George F. Wohlford, Benjamín Van Tassell, Hayley Billingsley et al. · Journal of Cardiovascular Pharmacology · 2020 · 138 citations · Full text

Heart Failure, Cardiovascular Pharmacology, Pharmacotherapy +18

The effects of canagliflozin compared to sitagliptin on cardiorespiratory fitness in type 2 diabetes mellitus and heart failure with reduced ejection fraction: The <scp>CANA‐HF</scp> study

Salvatore Carbone, Hayley Billingsley, Justin M. Canada et al. · Diabetes/Metabolism Research and Reviews · 2020 · 69 citations · Full text

Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trial

Paul Cremer, Antonio Abbate, Kristin Hudock et al. · The Lancet Rheumatology · 2021 · 68 citations · Full text

Sarcopenic Obesity Is Associated With Reduced Cardiorespiratory Fitness Compared With Nonsarcopenic Obesity in Patients With Heart Failure With Reduced Ejection Fraction

Hayley Billingsley, Marco Giuseppe Del Buono, Justin M. Canada et al. · Circulation Heart Failure · 2022 · 42 citations · Full text

Interleukin-1 blockade in cardiac sarcoidosis: study design of the multimodality assessment of granulomas in cardiac sarcoidosis: Anakinra Randomized Trial (MAGiC-ART)

Jordana Kron, Thomas Crawford, Virginia Mihalick et al. · Journal of Translational Medicine · 2021 · 40 citations · Full text